TCS 21311 (NIBR3049) is a potent, highly selective JAK3 inhibitor with an IC50 of 8 nM, it displays >100-fold selectivity over JAK1, JAK2 and TYK2. TCS 21311 (NIBR3049) inhibits PKCα, PKCθ, and GSK3β with IC50s of 13, 68, and 3 nM, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 2-3 weeks | $ 201 | |
2 mg | 2-3 weeks | $ 381 | |
4 mg | 2-3 weeks | $ 571 | |
10 mg | 2-3 weeks | $ 1051 | |
20 mg | 2-3 weeks | $ 1608 |
Description | TCS 21311 (NIBR3049) is a potent, highly selective JAK3 inhibitor with an IC50 of 8 nM, it displays >100-fold selectivity over JAK1, JAK2 and TYK2. TCS 21311 (NIBR3049) inhibits PKCα, PKCθ, and GSK3β with IC50s of 13, 68, and 3 nM, respectively. |
Targets&IC50 | JAK2: 2.55 μM, PKCα: 13 nM, JAK1: 1.017 μM, PKCθ: 68 nM, JAK3: 8 nM, GSK-3β: 3 nM |
Synonyms | NIBR3049 |
CAS No. | 1260181-14-3 |
Chemical Formula | C27H25F3N4O4 |
Molecular Weight | 526.516 |
Solubility | DMSO: ≥ 53 mg/mL (129.13 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom